Dingdang Kuaiyao obtained a new financing of $220 million from Pacific Century Capital as an important battle investment.

China Net Finance June 8 th On June 8 th, Dingdang Kuaiyao announced the completion of financing of 220 million US dollars. As an important strategic investor, PCG Capital participated in this round of financing, which is another high-quality project of PCG Capital Dollar Fund in the field of new pharmaceutical retail. Yang Wenlong, founder and chairman of Dangdang Express Medicine, said, "Next, we will go all out to speed up the digitalization of medical care and medicine and provide one-stop service for people's health."

According to the enterprise survey information, Dingdang Kuaiyao is a product that provides users with O2O medical services. It belongs to Dingdang Kuaiyao Technology Group Co., Ltd., which was established on 20 14, and its legal representative is Yang Yibin with a registered capital of 5294120,000 yuan. Its business scope includes: property management; Office rent; Prepackaged foods sales, except frozen food; Special food sales and so on. , its main shareholder is Zhuhai Dingdang Fourth Investment Center (Limited Partnership), holding 37.7778%.

Since Dangdang Kuaiyao was officially launched on February 6, 20 15, Dangdang Kuaiyao has continuously changed the traditional drug retail model through the mobile Internet to realize online and offline integrated operation. At present, Dangdang Express Medicine mainly has two business segments: online Dangdang Express Medicine Platform and offline Dangdang Smart Pharmacy. Dangdang Express Medicine Platform provides the ultimate health services such as 7*24 hours, 28 minutes home delivery and 24-hour medication guidance for professional pharmacists in core areas; Dingdang Smart Pharmacy is a self-operated offline chain pharmacy, which provides users with multi-scene services such as intelligent robot health monitoring, remote consultation in Internet hospitals, Internet access to Chinese medicine information, and chronic disease management.

Since 20 15, Dingdang Kuaiyao has carried out several rounds of financing.

On February 20th, 2065438+0616, Dingdang Kuaiyao obtained a Series A financing of 300 million yuan from a well-known investment institution.

2065438+20081October 28th, 65438+2008, Dingdang Kuaiyao announced that it had obtained a new round of financing, and the investor was Softbank China Capital (SBCVC), which is also the further layout of Softbank China in the pharmaceutical e-commerce industry.

2065438+On March 27th, 2009, a new pharmaceutical retailer, Dingdang Kuaiyao, announced the completion of a new round of financing of 600 million yuan, which will be mainly used to consolidate the existing business and expand innovative business.

On June 20th, 2020, 10, Dingdang Kuaiyao completed 10 billion RMB B+ round of financing. Taikang, Haier Medical, Longmen Investment, CMB Telecom Fund, Sinopharm Admiralty, Softbank China and other old shareholders jointly invested, with Huaxing Capital as the exclusive financial advisor.